Additional consent provisions for collection and use of participant data and biological specimens {26b}
This study includes blood draws for cardiometabolic risk markers (e.g., lipids, glycated hemoglobin (HbA1c)) as well as Alzheimer’s-related biomarkers (targeted metabolomics, lipidomics) and the genetic risk gene apolipoprotein E4 testing (APOE4). In the consent process, participants will have the opportunity to opt out of blood draws, opt out of genetic testing, and the option to opt out of receiving results of genetic testing.